Alternative splicing of SYK regulates mitosis and cell survival-Reference-Cited by-同舟云学术

Alternative splicing of SYK regulates mitosis and cell survival

Published:2011-05-08 Issue:6 Volume:18 Page:673-679
ISSN:1545-9993
Container-title:Nature Structural & Molecular Biology
language:en
Short-container-title:Nat Struct Mol Biol

Author:

Prinos Panagiotis,Garneau Daniel,Lucier Jean-François,Gendron Daniel,Couture Sonia,Boivin Marianne,Brosseau Jean-Philippe,Lapointe Elvy,Thibault Philippe,Durand Mathieu,Tremblay Karine,Gervais-Bird Julien,Nwilati Hanad,Klinck Roscoe,Chabot Benoit,Perreault Jean-Pierre,Wellinger Raymund J,Elela Sherif Abou

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Structural Biology

Link

http://www.nature.com/articles/nsmb.2040.pdf

Reference51 articles.

1. Pan, Q., Shai, O., Lee, L.J., Frey, B.J. & Blencowe, B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40, 1413–1415 (2008).

2. Wang, E.T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470–476 (2008).

3. Matlin, A.J., Clark, F. & Smith, C.W. Understanding alternative splicing: towards a cellular code. Nat. Rev. Mol. Cell Biol. 6, 386–398 (2005).

4. Castle, J.C. et al. Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat. Genet. 40, 1416–1425 (2008).

5. Venables, J.P. et al. Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol. 16, 670–676 (2009).

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agents;Expert Opinion on Investigational Drugs;2024-08-11

2. Phosphorylation of (Ser 291) in the linker insert of Syk negatively regulates ITAM signaling in platelets;Platelets;2024-06-21

3. A phase I study of TAK-659 and paclitaxel in patients with taxane-refractory advanced solid tumors;ESMO Open;2024-06

4. Proteomics Identifies LUC7L3 as a Prognostic Biomarker for Hepatocellular Carcinoma;Current Issues in Molecular Biology;2024-04-27

5. RNAi-based drug design: considerations and future directions;Nature Reviews Drug Discovery;2024-04-03